A PYMNTS Company

US: Alere sues Abbott over $5.8 billion takeover deal

By  |  August 28, 2016

Alere filed suit against Abbott Laboratories, claiming the medical device maker failed to get US antitrust clearance for the $5.8 billion merger underway between the two, potentially scuttling the controversial deal.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Abbott failed to “promptly secure antitrust approvals and other regulatory requirements,” Alere said in a filing in Delaware Chancery Court. The suit was filed under seal late Thursday and details weredisclosed in a filing on Friday.

    Abbott has tried to get out of the agreement, offering to pay $30 million to $50 million of Alere’s legal costs. That offer was immediately rejected by Alere’s board earlier this year.

    Full Content: Chicago Business

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.